Provided by Tiger Trade Technology Pte. Ltd.

Agenus

7.67
+0.13001.72%
Post-market: 7.680.0100+0.13%17:24 EDT
Volume:710.13K
Turnover:5.40M
Market Cap:345.31M
PE:3.07
High:7.79
Open:7.50
Low:7.38
Close:7.54
52wk High:10.31
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:0.60
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-1.73
PE(LYR):-2,258.54

Loading ...

Agenus Posts Investor Deck Spotlighting Botensilimab-Balstilimab Neoadjuvant Program in MSS Colon Cancer

Reuters
·
Aug 21

Agenus Modifies Loan and Issues Unregistered Equity

TIPRANKS
·
Aug 19

Agenus - Unit Enters Second Loan Modification Agreement with Ocean 1181 on Aug 12, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus - Loan Principal $24.75 Mln, Maturity Extended to Nov 30, 2029, Interest 13.0% Per Annum - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus Extends $24.75 Million Loan Maturity to Nov. 2029 in Ocean 1181 Amendment

Reuters
·
Aug 19

Agenus Grants CEO Garo Armen 1,971,500 Performance-Based Stock Options at $7.78 Per Share

Reuters
·
Aug 13

Agenus Strengthens Board With New Director Appointment

TIPRANKS
·
Aug 12

Agenus Tunjuk Marco Tullio Marcucci Sebagai Direktur Baru Dewan Komisaris

Reuters
·
Aug 12

Agenus Price Target Cut to $25.00/Share from $30.00 by HC Wainwright & Co.

Dow Jones
·
Aug 11

Agenus Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Agenus Files for Resale of Up to 78 Million Shares

MT Newswires Live
·
Aug 08

Agenus - Offers up to 77,976,718 Shares of Common Stock by Selling Securityholders - SEC Filing

THOMSON REUTERS
·
Aug 08

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Reuters
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Agenus Q2 Revenue Rises on Access and Royalty Income

Reuters
·
Aug 06

Agenus Swings to Q2 FY26 Net Loss of $0.6 Million; Revenue Rises 34.24% to $34.5 Million Year-over-Year

Reuters
·
Aug 06

Agenus Q2 Sales $34.500M Beat $34.000M Estimate

Benzinga Earnings
·
Aug 06

Agenus Q2 Operating Income USD 11.3 Million

Reuters
·
Aug 06

Agenus Reports Second Quarter 2026 Results and Advances Phase 3 Robbin Trial of BOT+Bal in Neoadjuvant Mss Colon Cancer

THOMSON REUTERS
·
Aug 06

Agenus - BOT+Bal Access Programs Contribute $6.40 Mln in Q2 Pre-Commercial Product Revenue

THOMSON REUTERS
·
Aug 06